TRI-JORDYNA 21

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: a4fd796ab68ff3d5
Drug Approval Canada Name: TRI-JORDYNA 21
Product Name: TRI-JORDYNA 21
Status: Marketed
Status Date: 2020-07-08
Original Market Date: 2020-07-08
Din: 02486296
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G03AB09 NORGESTIMATE AND ETHINYLESTRADIOL
Atc Name: g 03 ab 09
Aig Number: 0636783002
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

ETHINYL ESTRADIOL

0.035 MG

NORGESTIMATE

0.18 MG

NORGESTIMATE

0.215 MG

NORGESTIMATE

0.25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a4fd796ab68ff3d5

Type

Standard